Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Nov 05, 2024

BUY
$209.01 - $232.56 $67.2 Million - $74.8 Million
321,571 New
321,571 $70.3 Million
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $2.75 Million - $3.05 Million
13,136 Added 4.25%
322,461 $70.4 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $9.98 Million - $11.5 Million
50,490 Added 19.51%
309,325 $70.3 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $85,446 - $94,222
-425 Reduced 0.16%
258,835 $52 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $969,367 - $1.1 Million
-4,574 Reduced 1.73%
259,260 $62.6 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $13.4 Million - $16.2 Million
-62,712 Reduced 19.2%
263,834 $60.5 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $2.97 Million - $3.63 Million
14,580 Added 4.67%
326,546 $76.9 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $5.55 Million - $7.1 Million
-27,074 Reduced 7.99%
311,966 $63.9 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $13.4 Million - $17.5 Million
-62,824 Reduced 15.63%
339,040 $79.5 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $2.24 Million - $2.57 Million
-8,604 Reduced 2.1%
401,864 $106 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $26 Million - $30.1 Million
-95,721 Reduced 18.91%
410,468 $129 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $14.3 Million - $16.1 Million
52,126 Added 11.48%
506,189 $142 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $114 Million - $126 Million
454,063 New
454,063 $125 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.